Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 3 September 2002
Vol. 2002, Issue 148, p. tw327
[DOI: 10.1126/stke.2002.148.tw327]


Cancer Biology Signaling Brain Tumor Growth

Brain tumors are the leading cause of cancer-related deaths in children. The most common of these are medulloblastomas, highly aggressive tumors that arise in the cerebellum and whose molecular etiology is poorly understood. Berman et al. show that initiation and continued growth of these tumors requires the Hedgehog (Hh) cellular signaling pathway. Treatment of mice with cyclopamine, a plant-derived molecule that inhibits Hh signaling, caused regression of medulloblastomas with no apparent side effects; thus, small-molecule antagonists of Hh may merit investigation as a new therapy for human medulloblastoma.

D. M. Berman, S. S. Karhadkar, A. R. Hallahan, J. I. Pritchard, C. G. Eberhart, D. N. Watkins, J. K. Chen, M. K. Cooper, J. Taipale, J. M. Olson, P. A. Beachy, Medulloblastoma growth inhibition by Hedgehog pathway blockade, Science 297, 1559-1561 (2002). [Abstract] [Full Text]

Citation: Signaling Brain Tumor Growth. Sci. STKE 2002, tw327 (2002).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882